2022年12月14日 · Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though LVADs remain underused overall, the number of patients with heart failure supported with LVADs is steadily increasing.

Caspase-3（CPP32 / apopain）是关键效应器，因为它放大了来自启动器Caspase的信号，使用对Caspase-3有选择性的 DEVD肽序列 对活化的Caspase-3进行检测，可以检测Caspase-3的活性。

2023年8月8日 · Circulatory support with the use of a left ventricular assist device (LVAD) is an emerging field. The landmark REMATCH trial that compared LVADs with optimal medical therapy in class IV HF patients found a 48% reduction in mortality from any cause [4].

An understanding of the initial evaluation and management of patients with LVADs is now an essential skill for many health care providers. In this State-of-the-Art Review, we discuss current LVAD technology, summarize our clinical experience with LVADs, and review the current data for the medical management of patients living with LVADs.

2018年12月10日 · Mechanical circulatory support (MCS) with ventricular assist device (VAD) is a safe and efficacious treatment strategy for patients with end-stage heart failure (HF) that is refractory to medical therapy, 1–3 with >22 000 devices implanted to date in America and >2500 new implants occurring annually. 4 Although these patients appreciate 81% ...

2019年4月4日 · Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure with reduced ejection fraction. Although these devices effectively improve survival, atrial and ventricular arrhythmias are common, predispose these patients to additional risk, and complicate patient management.

A left ventricular assist device (LVAD) is a pump for patients with advanced heart failure. Once implanted, the LVAD is designed to help the left ventricle of your patient’s heart pump blood to the rest of their body.

A left ventricular assist device (LVAD) is a mechanical pump that providers implant in people who have heart failure. The device helps the lower left chamber (left ventricle) of your heart pump blood out of the ventricle to your aorta and the rest of your body.

Over the past two decades, mechanical circulatory support and left ventricular assist devices (LVAD) have altered the heart failure management landscape. Herein we review the indications for LVAD implantation and how they have changed over time.

Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though LVADs remain underused overall, the number of patients with heart failure ...